홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Naratriptan

HCID 4440
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
121679-13-8
표준 SMILES
CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1
InChIKey
AMKVXSZCKVJAGH-UHFFFAOYSA-N
분자식
C17H25N3O2S
평균 분자량
335.5 g/mol
단동위원소 질량
335.16674804

개요

Naratriptan is a member of tryptamines, a sulfonamide and a heteroarylpiperidine. It has a role as a serotonergic agonist and a vasoconstrictor agent.

이름 및 식별자

우선 이름
Naratriptan
IUPAC
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide
영어명
Naratriptan
분자식
C17H25N3O2S
분자량
335.46

이름 및 동의어

naratriptan121679-13-8NaramigN-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamidenaratriptanum1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamideQX3KXL1ZA2N-Methyl-2-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)ethanesulfonamideN-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamideCHEBI:7478DTXSID7023354
이름 더 보기
Naratriptan1NaratriptaneNaratriptan(Amerge)Naratriptan, 10 mM in DMSOAMERGEGR-85548AN-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]ethanesulfonamideInhibitor,GR-85548A,5-hydroxytryptamine Receptor,inhibit,Serotonin Receptor,5-HT Receptor,Naratriptan
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethane-1-sulfonamideN-methyl-2-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)ethane-1-sulfonamideN-methyl-2-(3-(1-methyl-4-piperidyl)-1H-indol-5-yl)-ethanesulfonamideRefChem:57988DTXCID003354N02CC02N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide601-800-8

데이터베이스 식별자

CAS
121679-13-8
PubChem CID
4440
DTXSID
DTXSID7023354
ChEMBL
CHEMBL1278
ChEBI
CHEBI:7478
UNII
QX3KXL1ZA2
EC Number
601-800-8
Nikkaji
J550.688C

물성

구조 계산 물성

XLogP
2
극성 표면적
73.6 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
4
회전 가능 결합 수
5
무거운 원자 수
23
형식 전하
0
복잡도
483

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals

Pharmaceuticals -> Listed in ZINC15

LogP1.6
Solubility1.14e-01 g/L
Human Drugs · 2건

Breast Feeding; Lactation; Milk, Human; Serotonin Receptor Agonists; Serotonin 5-HT1 Receptor Agonists; Triptans; Vasoconstrictor Agents

Pharmaceuticals

Melting Point246 °C (hydrochloride salt)
Physical DescriptionSolid
Collision Cross Section174.3 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

물리화학적 성질

녹는점
170 · 170-171°
끓는 점
541.3 · 541.3±60.0 °C(Predicted)
밀도
1.227 · 1.227±0.06 g/cm3(Predicted)
산도 계수 (pKa)
11.52 · 11.52±0.40(Predicted)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

Treatment · 1건

There is no specific antidote to naratriptan. Standard supportive treatment should be applied as required. If the patient presents with chest pain or other symptoms consistent with angina pectoris, ECG monitoring should be performed for evidence of ischemia. (L1712)

Exposure RoutesWell absorbed (74% oral biovaility), absorption is rapid with peak plasma concentrations after 2-5 hours. The rate of absorption is slower during a migraine attack.
Toxicity Summary · 1건

Three distinct pharmacological actions have been implicated in the antimigraine effect of the triptans: (1) stimulation of presynaptic 5-HT1D receptors, which serves to inhibit both dural vasodilation and inflammation; (2) direct inhibition of trigeminal nuclei cell excitability via 5-HT1B/1D receptor agonism in the brainstem and (3) vasoconstriction of meningeal, dural, cerebral or pial vessels as a result of vascular 5-HT1B receptor agonism.

Signs and SymptomsSymptoms of overdose include light-headedness, loss of coordination, tension in the neck, and tiredness.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 5건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

naratriptan

DILI Negative

Oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

화학 및 산업

약리 정보

ATC Code · 3건

N02CC02

N - Nervous system

QN - Nervous system

Protein Binding28%-31% (over the concentration range of 50 to 1000 ng/mL)
Pharmacodynamics · 1건

Naratriptan is a selective agonist of serotonin (5-hydroxytryptamine; 5-HT) type 1B and 1D receptors. It is structurally and pharmacologically related to other selective 5-HT1B/1D receptor agonist. Naratriptan has only a weak affinity for 5-HT<sub>1A</sub>, 5-HT<sub>5A</sub>, and 5-HT<sub>7</sub> receptors and no significant affinity or pharmacological activity at 5-HT<sub>2</sub>, 5-HT<sub>3</sub> or 5-HT<sub>4</sub> receptor subtypes or at alpha1-, alpha2-, or beta-adrenergic, dopamine1,; dopamine2; muscarinic, or benzodiazepine receptors. This action in humans correlates with the relief of migraine headache. In addition to causing vasoconstriction, experimental data from animal studies show that Naratriptan also activates 5-HT<sub>1</sub> receptors on peripheral terminals of the trigeminal nerve innervating cranial blood vessels, which may also contribute to the antimigrainous effect of Naratriptan in humans.

Mechanism of Action · 1건

Three distinct pharmacological actions have been implicated in the antimigraine effect of the triptans: (1) stimulation of presynaptic 5-HT1D receptors, which serves to inhibit both dural vasodilation and inflammation; (2) direct inhibition of trigeminal nuclei cell excitability via 5-HT1B/1D receptor agonism in the brainstem and (3) vasoconstriction of meningeal, dural, cerebral or pial vessels as a result of vascular 5-HT1B receptor agonism.

Biological Half-Life5-8 hours
Metabolism/Metabolites · 2건

Primarily hepatic. <i>In vitro,</i> naratriptan is metabolized by a wide range of cytochrome P450 isoenzymes into a number of inactive metabolites.

Primarily hepatic. <i>In vitro,</i> naratriptan is metabolized by a wide range of cytochrome P450 isoenzymes into a number of inactive metabolites. Half Life: 5-8 hours

FDA Pharmacological Classification · 6건

QX3KXL1ZA2

NARATRIPTAN

Mechanisms of Action [MoA] - Serotonin 1b Receptor Agonists

Mechanisms of Action [MoA] - Serotonin 1d Receptor Agonists

Established Pharmacologic Class [EPC] - Serotonin-1b and Serotonin-1d Receptor Agonist

Naratriptan is a Serotonin-1b and Serotonin-1d Receptor Agonist. The mechanism of action of naratriptan is as a Serotonin 1b Receptor Agonist and Serotonin 1d Receptor Agonist.

MeSH Pharmacological Classification · 2건

Drugs used to cause constriction of the blood vessels.

Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.

Absorption, Distribution and Excretion · 3건

Well absorbed (74% oral biovaility), absorption is rapid with peak plasma concentrations after 2-5 hours. The rate of absorption is slower during a migraine attack.

170 L

6.6 mL/min/kg

Cellular LocationsCytoplasm

용도 및 제조

Uses · 2건

Use (kg; approx.) in Germany (2009): >10

For the acute treatment of migraine attacks with or without aura in adults.

Use ClassificationPharmaceuticals
응용 분야 · 2건

용도Naratriptan is a triptan drug that is used for the treatment of migraine headaches.

일반 설명Naratriptan, the third triptan approved in 1998, is one of themost lipophilic triptans marketed to date. It has a much improvedbioavailability (63% in men and 74% in women), agreater affinity for 5-HT1B/1D receptors (3–6 times), and alower recurrence rate than sumatriptan because of its muchlonger elimination half-life. Naratritan also has a favorableCNS side effect profile when compared with sumatriptanor zolmitriptan because of its metabolic stability,thereby lacking a N-demethylated active metabolite and asignificant renal excretion ( 70% of naratriptan is excretedunchanged and the rest of the administered dose is degradedvia several CYP isozymes).

상·하류 제품 정보

상류 원료

메틸(1-)-4-피페리돈(1-메틸-피페리딘-4-일)-아세트알데히드Palladium hydroxide옥살산N-메틸-1H-인돌-5-에탄술폰아미드

관련 반응

8건
반응 기록 만들기
HRID 94643 반응식
HRID 94643생성물로
HRID 358594 반응식
HRID 358594생성물로
HRID 358595 반응식
HRID 358595반응물로
HRID 358597 반응식
HRID 358597반응물로
HRID 1028409 반응식
HRID 1028409반응물로
HRID 1028410 반응식
HRID 1028410생성물로
HRID 1028422 반응식
HRID 1028422반응물로
HRID 1028423 반응식
HRID 1028423반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트